244 related articles for article (PubMed ID: 18480940)
41. Medical management of Crohn's disease: a guide for radiologists.
Helper DJ
Eur J Radiol; 2009 Mar; 69(3):371-4. PubMed ID: 19223133
[TBL] [Abstract][Full Text] [Related]
42. Infliximab dependency is related to decreased surgical rates in adult Crohn's disease patients.
Pedersen N; Duricova D; Lenicek M; Elkjaer M; Bortlik M; Andersen PS; Vitek L; Davidsen B; Wewer V; Lukas M; Munkholm P
Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1196-203. PubMed ID: 20739896
[TBL] [Abstract][Full Text] [Related]
43. Toxicity of infliximab in the course of treatment of Crohn's disease.
Bratcher JM; Korelitz BI
Expert Opin Drug Saf; 2006 Jan; 5(1):9-16. PubMed ID: 16370952
[TBL] [Abstract][Full Text] [Related]
44. Infliximab-induced palmoplantar pustulosis in a patient with crohn disease.
Sladden MJ; Clarke PJ; Wettenhall J
Arch Dermatol; 2007 Nov; 143(11):1449. PubMed ID: 18025378
[No Abstract] [Full Text] [Related]
45. Re: Fefferman et al.--"Recurrence" of chronic pancreatitis appearing on a patient with underlying Crohn's disease.
Triantafillidis JK; Cheracakis P
Am J Gastroenterol; 2002 Mar; 97(3):761-2. PubMed ID: 11922579
[No Abstract] [Full Text] [Related]
46. Spontaneous regression of colonic lymphoma following infliximab and azathioprine withdrawal in patients with Crohn's disease.
Flynn AD; Azar JM; Chiorean MV
Inflamm Bowel Dis; 2013 Apr; 19(5):E69-70. PubMed ID: 23399737
[No Abstract] [Full Text] [Related]
47. [Maintenance treatment by anti-tumor necrosis factor monoclonal antibody in Crohn's disease--long-term effects and safety].
Matsui T
Nihon Shokakibyo Gakkai Zasshi; 2008 May; 105(5):649-58. PubMed ID: 18460853
[No Abstract] [Full Text] [Related]
48. Prolonged duration of response to infliximab in early pediatric Crohn's disease.
Kugathasan S
J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S40-3. PubMed ID: 11685975
[No Abstract] [Full Text] [Related]
49. Disseminated tuberculosis in a Crohn's disease patient on anti-TNF alpha therapy despite chemoprophylaxis.
Bourikas LA; Kourbeti IS; Koutsopoulos AV; Koutroubakis IE
Gut; 2008 Mar; 57(3):425; author reply 425-6. PubMed ID: 18268059
[No Abstract] [Full Text] [Related]
50. Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks.
Prescrire Int; 2007 Oct; 16(91):194. PubMed ID: 17926832
[TBL] [Abstract][Full Text] [Related]
51. Remicade approved for children with Crohn's disease.
FDA Consum; 2006; 40(4):6. PubMed ID: 17245830
[No Abstract] [Full Text] [Related]
52. Case of psoriasiform and pustular eruptions in addition to alopecia as a paradoxical reaction induced by infliximab.
Shimokata M; Namiki T; Tokoro S; Ugajin T; Miura K; Yokozeki H
J Dermatol; 2018 Dec; 45(12):e331-e333. PubMed ID: 29855072
[No Abstract] [Full Text] [Related]
53. Cutaneous Pseudolymphoma in a Patient With Crohn's Disease Under Infliximab: First Report.
Carvalhana S; Gonçalves A; Velosa J
J Clin Gastroenterol; 2016; 50(5):436-7. PubMed ID: 26974759
[No Abstract] [Full Text] [Related]
54. [Systemic candidiasis and infliximab therapy].
Belda A; Hinojosa J; Serra B; García L; Merino C; Belda A; Molés JR
Gastroenterol Hepatol; 2004; 27(6):365-7. PubMed ID: 15207136
[TBL] [Abstract][Full Text] [Related]
55. An Unusual Cause of Skin Rash in Crohn's Disease.
Chebli JMF; de Oliveira Moreira B; da Rocha Ribeiro TC
Gastroenterology; 2018 Sep; 155(3):618-620. PubMed ID: 29409941
[No Abstract] [Full Text] [Related]
56. Psoriasis induced by infliximab in a patient suffering from Crohn's disease.
Manni E; Barachini P
Int J Immunopathol Pharmacol; 2009; 22(3):841-4. PubMed ID: 19822070
[TBL] [Abstract][Full Text] [Related]
57. A Unique Infusion Reaction to Vedolizumab in a Patient With Crohn's Disease.
Gold SL; Magro C; Scherl E
Gastroenterology; 2018 Oct; 155(4):981-982. PubMed ID: 29614303
[No Abstract] [Full Text] [Related]
58. Infliximab treatment for symptomatic Crohn's disease strictures.
Pelletier AL; Kalisazan B; Wienckiewicz J; Bouarioua N; Soulé JC
Aliment Pharmacol Ther; 2009 Feb; 29(3):279-85. PubMed ID: 19035967
[TBL] [Abstract][Full Text] [Related]
59. Infliximab-induced acne: report of two cases.
Bassi E; Poli F; Charachon A; Claudepierre P; Revuz J
Br J Dermatol; 2007 Feb; 156(2):402-3. PubMed ID: 17223901
[No Abstract] [Full Text] [Related]
60. Occurrence of pustular psoriasis after treatment of Crohn disease with infliximab.
Pourciau C; Shwayder T
Pediatr Dermatol; 2010; 27(5):539-40. PubMed ID: 20796241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
